Advertisement

Die Poliomyelitis und ihre Erreger

Zusammenfassung

Die Polioviren bilden zusammen mit den Coxsackie-A-Viren, den Coxsackie-B-Viren und den ECHO-Viren die Gruppe der Enteroviren. Der Name Enteroviren bringt die Tatsache zum Ausdruck, daß der Intestinaltrakt der wichtigste Ort für die Ansiedlung und Vermehrung dieser Viren ist. Weitere gemeinsame Charakteristika der ganzen Gruppe sind neben der gleichen Art und Weise der Ausbreitung von Mensch zu Mensch der Gehalt an Ribonukleinsäure (RNS), die Unempfindlichkeit gegen Behandlung mit Diäthyläther und die Übereinstimmung in den äußeren Abmessungen der Viruspartikel. Ihre Durchmesser liegen durchwegs bei 25–30 mµ. Da auch die ERC-Viren (ECHO-28-Rhino-Coryza-Viren) teilweise die gleichen Eigenschaften besitzen, wurde vor einiger Zeit vom internationalen Komitee für Enteroviren vorgeschlagen, beide Gruppen von Viren zu den sogenannten Picornaviren zusammenzufassen. Dieser Vorschlag fände auch dadurch eine Legitimation, daß heute eine ganze Anzahl von Enterovirustypen als Ursache von respiratorischen Infekten angesehen werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Schrifttum

  1. 1.
    Alexander, H. E., G. Koch, J. Morgan-Mountain a. O. van Damm: Infectivity of RNA from poliovirus in human cell monolayers. J. Exper. Med. 108, 493 (1958)Google Scholar
  2. 2.
    Anders, W.: Die epidemiologische Situation der Poliomyelitis. In: Wöhler, F. u. O. Vivell: Klinische Probleme der Poliomyelitis und verwandter Viruskrankheiten. Springer-Verlag, Berlin-Göttingen-Heidelberg 1961Google Scholar
  3. 3.
    Baltimore, D., Y. Becker a. J. E. Darnell: Virus-specific double-stranded RNA in poliovirus infected cells. Science 143, 1034 (1964)PubMedGoogle Scholar
  4. 4.
    Black, M. L. a. E. A. Timm: Kinetics of the formalin inactivation of poliovirus. J. Med. Chem. 6, 624 (1963)PubMedGoogle Scholar
  5. 5.
    Bodian, D.: Poliomyelitis: Pathogenesis and histopathology. In: Rivers-Horsfall: Viral and rickettsial infections of man. Lippincott Comp., Philadelphia-London 1959. Daselbst weitere Literatur.Google Scholar
  6. 6.
    Bodian, D.: Experimental studies on passive immunization against poliomyelitis. I. Protection with human gamma globulin against intramuscular inoculation and combined passive and active immunization. Amer. J. Hyg. 54, 132 (1951)PubMedGoogle Scholar
  7. 7.
    Bodian, D.: Experimental studies on passive immunization against poliomyelitis. II. The prophylactic effect of human gamma globulin on paralytic poliomyelitis in cynomolgus monkeys after virus feeding. Amer. J. Hyg. 56, 78 (1952)PubMedGoogle Scholar
  8. 8.
    Bodian, D.: Experimental studies on passive immunization against poliomyelitis. III. Passive-active immunization and pathogenesis after virus feeding in Chimpanzees. Amer. J. Hyg. 58, 81 (1953)PubMedGoogle Scholar
  9. 9.
    Bodian, D.: Experimental poliomyelitis following intramuscular virus injection. III. The effect of passive antibody on paralysis and viremia. Bull. Johns Hopkins Hosp. 111, 198 (1962)PubMedGoogle Scholar
  10. 10.
    Bodian, D.: An electron-microscopic study of the monkey spinal cord. III. Cytologic effects of mild and virulent poliovirus infection. Bull. Johns Hopkins Hosp. 114, 21 (1964)Google Scholar
  11. 11.
    Bodian, D. a. R. S. Paffenbarger: Poliomyelitis infection in households. Frequency of viremia and specific antibody response. Amer. J. Hyg. 60, 83 (1954)PubMedGoogle Scholar
  12. 12.
    Boeye, A.: Induction of a mutation in poliovirus by nitrous acid. Virology 9, 691 (1959)PubMedGoogle Scholar
  13. 13.
    Le Bouvier, G. L., C. E. Schwerdt a. F. L. Schaffer: Specific precipitates in agar with purified poliovirus. Virology 4, 590 (1957)Google Scholar
  14. 14.
    Boyd, T. E.: Immunization against poliomyelitis. Bact. Rev. 17, 339 (1953) Suppl.PubMedGoogle Scholar
  15. 15.
    Carp, R. J. a. H. Koprowski: Mutation of type 3 poliovirus with nitrous acid. Virology 17, 99 (1962)PubMedGoogle Scholar
  16. 16.
    Crowthes, D. u. J. L. Melnick: Studies on the inhibitory action of guanidinc on poliovirus multiplication in cell cultures. Virology 15, 65 (1961)Google Scholar
  17. 17.
    Cox, H. R., V. J. Cabasso, J. Embil, F. S. Markham, M. J. Moses, A. W. Moyer, M. Roca-Garcia, a. J. M. Ruegsegger: Immunological response to trivalent oral poliomyelitis vaccine. Brit. Med. J. II, 591 (1959)Google Scholar
  18. 18.
    Cox, H. R., V. J. Cabasso, J. Embil, F. S. Markham, M. J. Moses, A. W. Moyer, M. Roca-Garcia, A. J. M. Ruegsegger: Further studies on immunological response to trivalent oral poliomyelitis vaccine. Papers and discussions presented at the Fifth International Poliomyelitis Conference Copenhagen 1960. J. B. Lippincott Comp., Philadelphia-Montreal 1961.Google Scholar
  19. 19.
    J. E. Darnell a. H. Eagle: The biosynthesis of polioviruses in cell cultures. Advances in Virus Res. 7, 1 (1960)Google Scholar
  20. 20.
    Dubes G. R. a. M. Chapin: Poliovirus mutants with altered responses to cystine. J. Gen. Microbiol. 18, 320 (1958)PubMedGoogle Scholar
  21. 21.
    Eggers, H. J., D. Baltimore a. j. Tamm: The relation of protein synthesis to formation of poliovirus RNA Polymerase. Virology 21, 281 (1963)PubMedGoogle Scholar
  22. 22.
    Fanconi, G.: Poliomyelitis und verwandte neurotrope Viruskrankheiten. In: Bergmann-Frey-Schwiegk: Handbuch der inneren Medizin I (1), 514 (1952)Google Scholar
  23. 23.
    Fogel, A. a. E. Eylan: Serodifferentiation of virulent and attenuated polioviruses by adsorbed sera. Virology 20, 533 (1963)PubMedGoogle Scholar
  24. 24.
    Fogh, J. a. D. C. Stuart: Intracellular crystals of polioviruses in HeLa cells. Virology 11, 308 (1960)PubMedGoogle Scholar
  25. 25.
    Francis, Th., J. A. Napier, R. B. Voight, F. M. Hemphill, H. A. Wenner, R. F. Korns, M. Boisen, E. Tolchinsky a. E. L. Diamond: Evaluation of the 1954 field trial of poliomyelitis vaccine — Final report. Poliomyelitis Vaccine Evaluation Center, Department of Epidemiology School of Public Health. University of Michigan, Ann Arbor, Michigan 1957Google Scholar
  26. 26.
    Gard, S.: Theoretical considerations in the inactivation of viruses by chemical means. Annals New York Academ. Sciences 83, 638 (1960)Google Scholar
  27. 27.
    Gard, S.: Immunological strain specificity within type 1 poliovirus. Bull. World Health Org. 22, 235 (1960)PubMedGoogle Scholar
  28. 28.
    Ghendon, Yu. Z.: Mutations of virulent and attenuated poliovirus strains induced by nitrous acid. Acta virol. 7, 16 (1963)Google Scholar
  29. 29.
    Gierer, A. u. G. Schramm: Die Infektiosität der Nukleinsäure aus Tabakmosaikvirus. Z. Naturforsch. 11b, 138 (1956)Google Scholar
  30. 30.
    Grasset, F., V. Bonifas a. E. Pongratz: Rapid slide precipitin microreaction of poliomyelitis antigens and antisera in agar. Proc. Soc. Exper. Biol. Med. 97, 72 (1958)Google Scholar
  31. 31.
    Haas, R., W. Keller u. W. Kikuth: Grundsätzliches zur aktiven Schutzimpfung gegen Poliomyelitis. Dtsch. med. Wschr. 80, 273 (1955)PubMedGoogle Scholar
  32. 32.
    Haas, R., R. Thomssen, G. Maass u. A. Gieseler: Über die Verwendung von Aluminiumhydroxyd zur Reinigung und Differenzierung von Enteroviren. 1. Untersuchungen über die Adsorption und Elution von Polioviren unter Verwendung von Aluminiumhydroxyd als Adsorbens. Z. Hyg. 148, 2 (1961)Google Scholar
  33. 33.
    Haas, R., G. Maass u. R. Thomssen: Das unterschiedliche Verhalten verschiedener Enterovirusstämme bei der Elution von Aluminiumhydroxyd als ein Virusmerkmal. Behringwerk-Mitteilungen 42, 14 (1962)Google Scholar
  34. 34.
    Hodes, H. L., H. D. Zepp a. E. A. Ainbender: A physical property as a virus marker: Difference in avidity of cellulose resin for virulent (Mahoney) and attenuated (LSc2ab) strain of type 1 poliovirus. Second International Conference on Live Poliovirus Vaccines, Washington 1960Google Scholar
  35. 35.
    Holland, J. J. a. L. C. Mc Laren: The mammalian cell-virus relationship. II. Adsorption, reception and eclipse of poliovirus by HeLa cells. J. Exper. Med. 109, 487 (1959)Google Scholar
  36. 36.
    Holland, J. J., L. C. Mc Laren a. J. T. Syverton: The mammalian cell-virus relationship. IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J. Exper. Med. 110, 65 (1959)Google Scholar
  37. 37.
    Horne, R. W. a. J. Nagington: Electron microscopy studies of the development and structure of poliomyelitis virus. J. Mol. Biol. 1, 333 (1959)Google Scholar
  38. 38.
    Horstmann, D. M., R. W. Mc Collum a. A. D. Mascola: Viremia in human poliomyelitis. J. Exper. Med. 99, 355 (1954)Google Scholar
  39. 39.
    Howe, H. A. u. J. L. Wilson: poliomyelitis. In: Rivers, Th. M. u. F. L. Horsfall: Viral and rickettsial infections of man.Google Scholar
  40. 40.
    Hummeler, H. a. J. J. Tumilonicz: Studies on the complement-fixing antigens of poliomyelitis. 2. Preparation of type-specific anti-N and anti-H-indicator Sera. J. Immunol. 84, 630 (1960)PubMedGoogle Scholar
  41. 41.
    Hummeler, K., T. F. Anderson a. R. A. Brown: Identification of poliovirus of different antigenicity by specific agglutination as seen in the electron microscope. Virology 16, 84 (1962)PubMedGoogle Scholar
  42. 42.
    Kanda, Y. a. J. L. Melnick: In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J. Exper. Med. 109, 9 (1959)Google Scholar
  43. 43.
    Koch, G.: Influence of assay conditions on infectivity of heated poliovirus. Virology 12, 601 (1960)PubMedGoogle Scholar
  44. 44.
    Koprowski, H.: Immunization of man against poliomyelitis with attenuated preparations of living virus. Ann. N. Y. Acad. Sc. 61, Art. 4, 1039 (1955)Google Scholar
  45. 45.
    Koprowski, H., G. A. Jervis, T. W. Norton a. D. J. Nielsen: Further studies on oral administration of living poliomyelitis virus to human subjects. Proc. Soc. Exper. Biol. Med. 82, 277 (1963)Google Scholar
  46. 46.
    Kubinski, H. a. G. Koch: On the separation of poliovirus ribonucleic acid. Virology 17, 219 (1962)PubMedGoogle Scholar
  47. 47.
    Lennette, E. H., R. L. Magoffin a. N. J. Schmidt: Observations on the complement-fixing antibody response in human poliomyelitis. Influence of age and vaccination status. J. Immunol. 89, 358 (1962)PubMedGoogle Scholar
  48. 48.
    Lennette, E. H., N. J. Schmidt, R. L. Magoffin, Sh. J. Hagens a. E. J. Dukellis: A comparison of the reactivity of poliovirus complement-fixing antigens (native, heated and sucrose density gradient C and D) with human Sera. J. Immunol. 92, 261 (1964)PubMedGoogle Scholar
  49. 49.
    Levintow, L. a. J. E. Darnell: A simplified procedure for purification of large amounts of poliovirus: Characterization and amino acid analysis of type 1 poliovirus. J. Biol. Chem. 235, 70 (1960)PubMedGoogle Scholar
  50. 50.
    Levintow, L., M. M. Thoren, J. E. Darnell a. J. L. Hooper: Effect of p-fluor-phenylalanine and puromycin on the replication of poliovirus. Virology 16, 220 (1962)PubMedGoogle Scholar
  51. 51.
    Loddo, B.: Inibizione della moltiplicazione in vitro di virus poliomielitici ad opera della guanidina. Boll. Soc. Ital. Biol. Sper. 35, 395 (1961)Google Scholar
  52. 52.
    Loddo, B., B. Scarpa a. S. Muntoni: Infective “ribonucleic acid” extraction from poliovirus by sodium dodecyl sulfate. Experientia 19, 246 (1963)PubMedGoogle Scholar
  53. 53.
    Lwoff, A.: The thermosensitive critical event of the viral cycle. Cold Spring Harbor Symposia Quant. Biology 27, 159 (1962)Google Scholar
  54. 54.
    Lwoff, A. et M. Lwoff: L’inhibition du développement du virus poliomyélitique à 39° et le problème du rôle de l’hyperthermie dans l’évolution des infections virales. Compt. rend. acad. Sc. 246, 190 (1958)Google Scholar
  55. 55.
    Mc Bride, W. D.: Antigenic analysis of polioviruses by kinetic studies of serum neutralization. Virology 7, 45 (1959)PubMedGoogle Scholar
  56. 56.
    Mandel, B.: Early stages of virus-cell interaction as studied by using antibody. Cold Spring Harbor Symposia on Quantitative Biology 27, 123 (1962)Google Scholar
  57. 57.
    Mandel, B.: The use of sodium dodecyl sulfate in studies on the interaction of poliovirus and HeLa cells. Virology 17, 288 (1962)PubMedGoogle Scholar
  58. 58.
    Mandel, B.: The extraction of ribonucleic acid from poliovirus by treatment with sodium dodecyl sulfate. Virology 22, 360 (1964)PubMedGoogle Scholar
  59. 59.
    Mayer, M. M., H. J. Rapp, B. Roizman, S. W. Klein, K. M. Kowan, D. Luckens, C. E. Schwerdt, F. L. Schaffer a. J. Charney: The purification of poliomyelitis virus as studied by complement fixation. J. Immunol. 78, 435 (1957)PubMedGoogle Scholar
  60. 60.
    Mountain, J. M. a. H. E. Alexander: Infectivitiy of ribonucleic acid (RNA) from type I poliovirus in embryonated eggs. Proc. Soc. Exper. Biol. Med. 101, 527 (1959)Google Scholar
  61. 61.
    Murray, R., R. Kirschstein, G. van Hoosier a. S. Baron: Comparative virulence for rhesus monkeys of poliovirus strains used for oral administration. In: Live poliovirus vaccines. First International Conference on Live Poliovirus Vaccines, Washington 1959Google Scholar
  62. 62.
    Noetzel, H.: Die Pathologie der Poliomyelitis. In: Wöhler-Vivell: Klinische Probleme der Poliomyelitis und verwandter Viruskrankheiten. 8. Freiburger Symposion 1961. Springer, Heidelberg 1962Google Scholar
  63. 63.
    Oppenheimer, F., E. Benesi a. A. R. Taylor: The ultraviolet irradiation of biological fluids in thin-flowing films. Amer. J. Publ. Health 49, 903 (1959)Google Scholar
  64. 64.
    Paffenbarger, R. S. a. V. O. Wilson: Previous tonsillectomy and current pregnancy as they affect risk of poliomyelitis attack. Ann. N. Y. Acad. Sc. 61, 856 (1955)Google Scholar
  65. 65.
    Paul, J. R., J. L. Melnick a. J. T. Riordan: Comparative neutralizing antibody patterns to Lansing (type 2) poliomyelitis virus in different populations. Amer. J. Hyg. 56, 232 (1952)PubMedGoogle Scholar
  66. 66.
    Plotkin, S. A., R. J. Carp a. A. F. Graham: The poliovirus of man. Ann. N. Y. Acad. Sc. 101, Art. 2, 357 (1962)Google Scholar
  67. 67.
    Pohjanpelto, P.: Stabilization of poliovirus by cystine. Virology 6, 472 (1958)PubMedGoogle Scholar
  68. 68.
    Pohjanpelto, P.: Oxidation in thermoinactivation of polioviruses. Virology 16, 92 (1962)PubMedGoogle Scholar
  69. 69.
    Reich, E., R. M. Franklin, A. J. Shatkin a. E. L. Tatum: Effect of actinomycin D on cellular nucleic acid synthesis and virus production. Science 134, 556 (1961)PubMedGoogle Scholar
  70. 70.
    Reich, E., R. M. Franklin, A. J. Shatkin a. E. L. Tatum: Action of actinomycin on animal cells and viruses. Proc. Nat. Acad. Sc. 48, 1238 (1962)Google Scholar
  71. 71.
    Rightsel, W. A., J. R. Dice, R. J. Mc Alpine, E. A. Timm, J. W. Mc Lean jr., G. I. Dixon a. F. M. Schabel: Antiviral effect of guanidine. Science 134, 558 (1961)PubMedGoogle Scholar
  72. 72.
    Robbins, F. C.: Diskussionsbemerkung. In: Live poliovirus vaccines. Papers presented and discussions held at the Second International Conference on Live Poliovirus Vaccine. World Health Org., Washington 1960Google Scholar
  73. 73.
    Roizman, B., M. M. Mayer, a. H. J. Rapp: Immunochemical studies of poliovirus. III. Further studies on the immunologic and physical properties of poliovirus particles produced in tissue culture. J. Immunol. 81, 419 (1958)PubMedGoogle Scholar
  74. 74.
    Roizman, B., M. M. Mayer a. H. J. Rapp: Immunochemical studies of poliovirus. III. Further studies on the immunologic and physical properties of poliovirus particles produced in tissue culture. J. Immunol. 81, 419 (1958)PubMedGoogle Scholar
  75. 75.
    Ruschmann, E. u. R. Haas: Erfahrungen mit der Flockungsreaktion in Agar-Gel mit konzentriertem Poliomyelitis-Virus der Typen 1, 2, 3. Zschr. ges. Hyg u. Grenzgeb. 7, 697 (1961)Google Scholar
  76. 76.
    Sabin, A. B.: Behavior of chimpanzee-avirulent poliomyelitis viruses in experimentally infected human volunteers. Amer. J. Med. Sc. 230, 1 (1955)Google Scholar
  77. 77.
    Sabin, A. B.: Properties and behavior of orally administered attenuated poliovirus vaccine. Papers presented and discussions held at the Fourth International Poliomyelitis Conference 1957. J. B. Lippincott Comp., Philadelphia-Montreal 1958Google Scholar
  78. 78.
    Salk, J. E.: A concept of the mechanism of immunity for preventing paralysis in poliomyelitis. Ann. N. Y. Acad. Sc. 61, 4, 1023 (1955)Google Scholar
  79. 79.
    Salk, J. E.: Basic principles underlying immunization against poliomyelitis with a noninfectious vaccine. Papers presented and discussions held at the Fourth International Poliomyelitis Conference. J. B. Lippincott Comp., Philadelphia-MontrealGoogle Scholar
  80. 80.
    Salk, J. E. a. J. B. Gori: A review of theoretical, experimental and practical considerations in the use of formaldehyde for the inactivation of poliovirus. Ann. N. Y. Acad. Sc. 83, 609 (1960)Google Scholar
  81. 81.
    Salk, J. E., B. L. Bennett, L. J. Lewis, E. N. Ward a. J. S. Youngner: Studies in human subjects on active immunization against poliomyelitis. 1. A preliminary report of experiments in progress. J. Amer. Med. Ass. 151, 1081 (1953); 2. A practical means for inducing and maintaining antibody formation. Amer. J. Publ. Health 44, 994 (1954)Google Scholar
  82. 82.
    Schaffer, F. L., a. C. E. Schwerdt: Purification and properties of poliovirus. In: Advances in Virus Research 6, 159 (1959)PubMedGoogle Scholar
  83. 83.
    Schaffer, F. L., H. Fisher Moore a. C. E. Schwerdt: Base composition of the ribonucleic acids of the three types of poliovirus. Virology 10, 530 (1960)PubMedGoogle Scholar
  84. 84.
    Schaffer, F. L. a. A. J. Hackett: Early events in poliovirus — HeLa cell interaction: Acridin orange photosensitization and detergent extraction. Virology 21, 124 (1963)PubMedGoogle Scholar
  85. 85.
    Scharff, M. D. a. L. Levintow: Quantitative study of the formation of poliovirus antigens in infected HeLa cells. Virology 19, 491 (1963)PubMedGoogle Scholar
  86. 86.
    Scharff, M. D., J. V. Maizel a. L. Levintow: Physical and immunological properties of a precursor of the poliovirus capsid. Proc. Nat. Acad. Sc. 51, 329 (1964)Google Scholar
  87. 87.
    Schmidt, N. J. a. E. M. Lennette: A microflocculation test for poliomyelitis with observations on the flocculating antibody response in human poliomyelitis. J. Amer. Hyg. 70, 51 (1959)Google Scholar
  88. 88.
    Schmidt, W. A. H.: Untersuchungen zur Komplementbindungsreaktion der Poliomyelitis. 4. Die serologische Beschaffenheit verschiedener Typ-1- und Typ-2-Antigene. Arch. Virusforsch. 13, 358 (1962). Daselbst die früheren Arbeiten zitiertGoogle Scholar
  89. 89.
    Schmidt, W. A. H., W. Höpken u. R. Wohlrab: Untersuchungen zur Komplementbindungsreaktion der Poliomyelitis. 5. Verwendung von je 11 serologisch definierten Typ-1- und Typ-2-Antigenen bei der Untersuchung von Patientenseren. Arch. Virusforsch. 14, 521 (1964)PubMedGoogle Scholar
  90. 90.
    Schwerdt, C. E. u. F. L. Schaffer: Purification of poliomyelitis viruses propagated in tissue culture. Virology 2, 665 (1956)PubMedGoogle Scholar
  91. 91.
    Smith, W., F. W. Sheffield, L. H. Lee a. G. Churcker: A specific virus antibody flocculation reaction with poliovirus. Lancet 270, 710 (1956)PubMedGoogle Scholar
  92. 92.
    de Somer, P., A. Prinzie a. E. Schonne: Infectivity of poliovirus ribonucleic acid for embryonated eggs and insusceptible cell lines. Nature 184, 652 (1959)Google Scholar
  93. 93.
    Summary of the report of the National Advisory Committee for Evaluation of Gamma Globulin. J. Amer. Med. Ass. 154, 1086 (1954)Google Scholar
  94. 94.
    Takemori, N., S. Nomura, M. Nakano, Y. Morioka, M. Henmi a. M. Kitaoka: Mutation of poliovirus to resistance to neutralizing substances in normal bovine sera. Virology 5, 30 (1958)PubMedGoogle Scholar
  95. 95.
    Takemori, N. a. S. Nomura: Mutation of polioviruses with respect to size of plaque. II. Reverse mutation of minute plaque mutant. Virology 12, 171 (1960)PubMedGoogle Scholar
  96. 96.
    Takemoto, K. K. a. K. Habel: Sensitivity and resistance of type 1 poliovirus to an inhibitor in certain horse sera. Virology 9, 228 (1959)PubMedGoogle Scholar
  97. 97.
    Takemoto, K. K. a. R. L. Kirschstein: Dextran sulfate plaque mutants of attenuated type 1 poliovirus. J. Immunol. 92, 329 (1964)PubMedGoogle Scholar
  98. 98.
    Taylor, A. R.: Effects of nonionizing radiations on animal viruses. Ann. N. Y. Acad. Sc. 83, 670 (1960)Google Scholar
  99. 99.
    Thomssen, R.: Ein chromatographisches Verfahren zur Bestimmung typenspezifischer Poliovirus-Antikörper mit 32P-markiertem Poliovirus. Z. Naturforsch. 18b, 798 (1963)Google Scholar
  100. 100.
    Thomssen, R.: Determination of type-specific antibodies against poliovirus labelled with phosphorus-32 by an elution test. Nature 198, 613 (1963)PubMedGoogle Scholar
  101. 101.
    Thomssen, R., V. Dostal, R. Haas u. E. Ruschmann: Untersuchungen zur thermischen Resistenz von Polioviren. Arch. Virusforsch. 9, 571 (1960)PubMedGoogle Scholar
  102. 102.
    Thomssen, R. u. G. Maass: Über die Verwendung von Aluminiumhydroxyd zur Reinigung und Differenzierung von Enteroviren. 3. Das Verhalten der Poliovirusstämme Mahoney und LSc,2ab bei der Elution von Aluminiumhydroxyd als stabiles Merkmal. Z. Hyg. 148, 476 (1961)Google Scholar
  103. 103.
    Thomssen, R., G. Maass u. R. Haas: Über die Verwendung von Aluminiumhydroxyd zur Reinigung und Differenzierung von Enteroviren. 2. Unterschiedliches Verhalten verschiedener Poliovirusstämme (Wildstämme und abgeschwächte Stämme) bei der Elution von Aluminiumhydroxyd. Z. Hyg. 148, 14 (1961)Google Scholar
  104. 104.
    Vivell, O.: Viruskrankheiten. In: Keller-Wiskott: Lehrbuch der Kinderheilkunde. Georg Thieme Verlag, Stuttgart 1961Google Scholar
  105. 105.
    Vogt, M., R. Dulbecco a. H. A. Wenner: Mutants of poliomyelitis viruses with reduced efficiency of plating in acid medium and reduced neuropathogenicity. Virology 4, 141 (1957)PubMedGoogle Scholar
  106. 106.
    Wallis, C. a. J. L. Melnick: Cationic stabilization. A new property of enteroviruses. Virology 16, 504 (1962)PubMedGoogle Scholar
  107. 107.
    Wallis, C. a. J. L. Melnick: Thermal inactivation of poliovirus under anaerobic conditions. J. Bact. 84, 389 (1962)PubMedGoogle Scholar
  108. 108.
    Wallis, C., J. L. Melnick, G. D. Ferry a. J. L. Wimberly: An aluminium marker for the differentiation and separation of virulent and attenuated polioviruses. J. Exper. Med. 115, 763 (1962)Google Scholar
  109. 109.
    Wecker, E.: A simple test for serodifferentiation of poliovirus strains within the same type. Virology 10, 376 (1960)PubMedGoogle Scholar
  110. 110.
    Wecker, E.: Effect of puromycin on the replication of western equine encephalitis and poliomyelitis-viruses. Nature 197, 1277 (1963)PubMedGoogle Scholar

Copyright information

© J. F. Lehmanns Verlag München 1965

Authors and Affiliations

  • R. Haas

There are no affiliations available

Personalised recommendations